High and increasing prevalence of inflammatory bowel disease in Finland with a clear North–South difference  Airi Jussila, Lauri J. Virta, Veikko Salomaa,

Slides:



Advertisements
Similar presentations
Inflammatory Bowel Disease: Overview
Advertisements

The Prevalence and Geographic Distribution of Crohn’s Disease and Ulcerative Colitis in the United States  Michael D. Kappelman, Sheryl L. Rifas–Shiman,
Work disability in inflammatory bowel disease
The requirements and barriers to successful transition of adolescents with inflammatory bowel disease: Differing perceptions from a survey of adult and.
The risk of lymphoma and immunomodulators in patients with inflammatory bowel diseases: Results from a population-based cohort in Eastern Europe  Peter.
Risk of colorectal cancer and small bowel adenocarcinoma in Crohn's disease: A population-based study from western Hungary 1977–2008  Peter Laszlo Lakatos,
IBD in the elderly population: Results from a population-based study in Western Hungary, 1977���2008  Peter Laszlo Lakatos, Gyula David, Tunde Pandur,
How do psychological variables influence coping strategies in inflammatory bowel disease?  Marta Iglesias-Rey, Manuel Barreiro-de Acosta, Francisco Caamaño-Isorna,
Dermatological adverse reactions during anti-TNF treatments: Focus on inflammatory bowel disease  Giammarco Mocci, Manuela Marzo, Alfredo Papa, Alessandro.
Anti-tumor necrosis factor-α induced systemic lupus erythematosus in a patient with metastatic Crohn's disease—what is the role of anti-TNF antibody? 
Concurrent small bowel adenocarcinoma and carcinoid tumor in Crohn's disease — Case report and literature review  Doron Boltin, Zohar Levi, Marisa Halpern,
Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome 
YouTube® and inflammatory bowel disease
A case report: Ulcerative colitis, treatment with an antibody against tumor necrosis factor (infliximab), and subsequent liver necrosis  Urpo Kinnunen,
Incidence of ulcerative colitis and Crohn's disease in Danish children: Still rising or levelling out?  Christian Jakobsen, Vibeke Wewer, Frederikke Urne,
Primary biliary cirrhosis developing in a patient with Crohn's disease during the course of infliximab treatment: The first case in the literature  Gurhan.
Preoperative use of anti-TNF therapy and postoperative complications in inflammatory bowel diseases: A meta-analysis  Vincent Billioud, Alexander C. Ford,
High and increasing prevalence of inflammatory bowel disease in Finland with a clear North–South difference  Airi Jussila, Lauri J. Virta, Veikko Salomaa,
Disease severity does not affect the interval between IBD diagnosis and the development of CRC: Results from two large, Dutch case series  Erik Mooiweer,
Prevalence of irritable bowel syndrome (IBS) in first-degree relatives of patients with inflammatory bowel disease (IBD)  Mariam Aguas, Vicente Garrigues,
Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome 
A. J. Walsh, M. Weltman, D. Burger, S. Vivekanandarajah, S. Connor, M
Microscopic colitis patients have increased proportions of Ki67+ proliferating and CD45RO+ active/memory CD8+ and CD4+8+ mucosal T cells  Ashok Kumar.
Anterior ischemic optic neuropathy in a patient with Crohn's disease and aberrant MTHFR and GPIIIa gene variants  T. Felekis, K.H. Katsanos, C.D. Zois,
Serum prohepcidin levels in chronic inflammatory bowel diseases
Charlotte de Bie, Angelika Kindermann, Johanna Escher 
N. Kjaersgaard Nielsen, V. Wewer, L. Skafte, A. Paerregaard 
Endothelial function and cardiovascular risk in active inflammatory bowel diseases  Mariabeatrice Principi, Mario Mastrolonardo, Pietro Scicchitano, Michele.
Fatal Colonic Perforation in a Pregnant with Behçet's Disease
Filiform polyposis associated with sigmoid diverticulitis in a patient without inflammatory bowel disease  Hyun-Soo Kim, Kil Yeon Lee, Youn Wha Kim  Journal.
Familial aggregation in Crohn's disease and ulcerative colitis in a Norwegian population- based cohort followed for ten years  May-Bente Bengtson, Camilla.
Public awareness of Crohn's disease and ulcerative colitis: A national survey  Sieglinde Angelberger, Harald Vogelsang, Gottfried Novacek, Wolfgang Miehsler,
Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome 
B. Sicilia, F. Arribas, J. Nerín, C. López Miguel, R. Vicente, F
Incidence of ulcerative colitis and Crohn's disease in Danish children: Still rising or levelling out?  Christian Jakobsen, Vibeke Wewer, Frederikke Urne,
Activated thrombin activatable fibrinolysis inhibitor (TAFIa) is associated with inflammatory markers in inflammatory bowel diseases  Danuta Owczarek,
Canadian cost-utility analysis of initiation and maintenance treatment with anti-TNF-α drugs for refractory Crohn's disease  Gord Blackhouse, Nazila Assasi,
Age-related differences in presentation and course of inflammatory bowel disease: an update on the population-based literature  Dana Duricova, Johan Burisch,
Iron replacement therapy in inflammatory bowel disease patients with iron deficiency anemia: A systematic review and meta-analysis  Thomas W. Lee, Michael.
Reply Gastroenterology
Volume 147, Issue 4, Pages e7 (October 2014)
Paula Borralho, Ana Vieira, João Freitas, Paula Chaves, Jorge Soares 
Clinical trials in luminal Crohn's disease: A historical perspective
Xian-rui Wu, Saurabh Mukewar, Ravi P. Kiran, Feza H
The usefulness of factor XIII levels in Crohn's disease
Rapid improvement of refractory pyoderma gangrenosum with infliximab gel in a patient with ulcerative colitis  Niels Teich, Tobias Klugmann  Journal of.
Seth Lipka, Seymour Katz, Lev Ginzburg  Journal of Crohn's and Colitis 
Osteoporosis in inflammatory bowel disease
Pediatric pulmonary Crohn's disease: More frequent than expected
Suppurative granulomatous inflammation in the ileo-anal pouch
Ulrich Bonse-Geuking, Michael Kraus  Journal of Crohn's and Colitis 
Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome 
Pathogenic Escherichia coli in inflammatory bowel diseases
Increase in bone mineral density in strictly treated Crohn's disease patients with concomitant calcium and vitamin D supplementation  Sjoerd F. Bakker,
Canadian cost-utility analysis of initiation and maintenance treatment with anti-TNF-α drugs for refractory Crohn's disease  Gord Blackhouse, Nazila Assasi,
Reply Gastroenterology
Subrata Ghosh, Benjamin Pariente, Diane R
Yield and cost effectiveness of mycobacterial infection detection using a simple IGRA- based protocol in UK subjects with inflammatory bowel disease suitable.
Genotyping should be considered the primary choice for pre-treatment evaluation of thiopurine methyltransferase function  Ulf Hindorf, Malin Lindqvist.
Inflammatory Bowel Disease in South Limburg (the Netherlands) 1991–2002: Incidence, diagnostic delay, and seasonal variations in onset of symptoms  Mariëlle.
Yinghong Wang, Hua Gong, Rocio Lopez, Lei Lian, Ravi P. Kiran, Edy E
Surgical management of gluteal metastatic cutaneous Crohn's disease
Exclusive elemental diet impacts on the gastrointestinal microbiota and improves symptoms in patients with chronic pouchitis  S.D. McLaughlin, A. Culkin,
Bowel sonography in occlusive Crohn's disease
The role of in vitro interferonγ-release assay in differentiating intestinal tuberculosis from Crohn's disease in China  Yue Li, Li-fan Zhang, Xiao-qing.
Health-related quality of life in inflammatory bowel disease: Psychosocial, clinical, socioeconomic, and demographic predictors  Anilga Moradkhani, Linda.
Figure 1 Approximate timeline contrasting major historical events in the understanding of ulcerative colitis (red) and ... Figure 1 Approximate timeline.
Reenu Malhotra, Kevin Turner, Amnon Sonnenberg, Robert M. Genta 
Meenakshi Bewtra, Chinyu Su, James D. Lewis 
The Prevalence and Geographic Distribution of Crohn’s Disease and Ulcerative Colitis in the United States  Michael D. Kappelman, Sheryl L. Rifas–Shiman,
Presentation transcript:

High and increasing prevalence of inflammatory bowel disease in Finland with a clear North–South difference  Airi Jussila, Lauri J. Virta, Veikko Salomaa, Juhani Mäki, Antti Jula, Martti A. Färkkilä  Journal of Crohn's and Colitis  Volume 7, Issue 7, Pages e256-e262 (August 2013) DOI: 10.1016/j.crohns.2012.10.007 Copyright © 2012 European Crohn's and Colitis Organisation Terms and Conditions

Figure 1 University Hospital regions in Finland. Journal of Crohn's and Colitis 2013 7, e256-e262DOI: (10.1016/j.crohns.2012.10.007) Copyright © 2012 European Crohn's and Colitis Organisation Terms and Conditions

Figure 2 Age specific prevalences of IBD in 2008 and age specific prevalences of CD and UC in 1993 calculated per 100,000 persons in Finland. Journal of Crohn's and Colitis 2013 7, e256-e262DOI: (10.1016/j.crohns.2012.10.007) Copyright © 2012 European Crohn's and Colitis Organisation Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.